We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
As per terms of the deal, United Therapeutics will acquire SteadyMed’s stock by paying $4.46 per share in cash. The deal also includes payment of an additional $2.63
The technology will help to accurately identify bleeds, fractures and other critical abnormalities in head CT scans. Qure.ai noted that the clinical validation study confirmed its algorithms' near-radiologist
The company closed series C financing under the round led by Deerfield Management, and the participants included new investors such as Endeavour Vision, Quark Venture and Aperture Venture
Crohn’s disease is one of the major forms of inflammatory bowel disease. The study is sponsored by Cambridge University Hospital NHS Foundation Trust and the University of Cambridge.
Australia-based Hostplus was the new investor and Oxford Finance made a venture debt contribution. Existing investors M. H. Carnegie, Arboretum Ventures, Lumira Capital, LSP Health Economics Fund and
The company unveiled their vision for the world’s first and only CRISPR-enabled platform capable of identifying any biomarker or disease containing DNA or RNA. Mammoth Biosciences is supported by venture capitalists including
The partnership has tested an implantable device, which renders islet cells with their own supply of oxygen through chamber that can be refilled every 24 hours, helping to
The Swiss firm created the ophthalmic digital research platform with ResearchKit. It enables researchers to track disease progression by collecting real-time and self-reported data directly from consenting patients. Collecting data
The latest LUCAS 3.1 version is an external mechanical device that will provide automatic chest compressions with a minimum of interruptions during resuscitation. It offers new capabilities for tailored
The company submitted an application requesting the agency to review it. The technology, which was invented at the Texas Heart Institute, allows for the early detection and monitoring